COAGHemab Therapeutics Holdings, Inc.

$34.37

Who owns COAG

55 institutions reported holding COAG for 2026Q2.

55

Institutions reporting a position · as of 2026Q2

Shares held by institutions
36.2M

Shares held by institutions · long US equity positions only, as reported on Form 13F

Reported value
$1.33B

Reported value · at Jun 30, 2026 prices, not today's

Opened vs closed
52 / 0

Opened vs closed · new positions against positions exited in the latest quarter

Details›
Reporting quarter2026-06-30
2026Q2
Quarters on record
1
New positions
52
Positions exited
0
Added to
0
Reduced
0
Shares sold shortsettled Sep 30, 2026
3.4M
Short interestof shares outstanding
7.3%
Days to coverat the average daily volume
4.2
Change in the short positionsince the Sep 15, 2026 count
+28%
Largest reported holders, 2026Q2
HolderShares% of companyValue
RA CAPITAL MANAGEMENT, L.P.7.8Mn/a$287M
NOVO HOLDINGS A/S4.2Mn/a$154M
FMR LLC3.7Mn/a$136M
Capital International Investors3.6Mn/a$132M
Deep Track Capital, LP3.6Mn/a$132M
Siren, L.L.C.2.1Mn/a$77M
Avoro Capital Advisors LLC1.9Mn/a$71M
Bain Capital Life Sciences Investors, LLC1.6Mn/a$61M
JPMORGAN CHASE & CO1.2Mn/a$42M
VANGUARD GROUP INC0.9Mn/a$33M
Short interest by settlement date, May 15, 2026 to Sep 30, 2026
SettlementShares shortOf shares outstandingDays to cover
Sep 30, 20263.4M7.3%4.2
Sep 15, 20262.6M5.7%7.5
Aug 31, 20262.1M4.5%6.0
Aug 14, 20262.0M4.4%6.2
Jul 31, 20262.0M4.4%4.3
Jul 15, 20261.7M3.6%5.3
Jun 30, 20261.7M3.7%4.0
Jun 15, 20261.4M2.9%7.5
May 29, 20261.0M2.2%6.5
May 15, 20260.8M1.6%1.2

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold. The short position is FINRA's consolidated count for each twice-monthly settlement date, as a share of shares outstanding.

opening the register…